{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T10:53:40Z","timestamp":1791543220909,"version":"4.3.4"},"reference-count":85,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T00:00:00Z","timestamp":1715212800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.ejso.2024.108391","type":"journal-article","created":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T22:00:31Z","timestamp":1715205631000},"page":"108391","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Chinese guidelines on the management of endometrial hyperplasia"],"prefix":"10.1016","volume":"50","author":[{"given":"Lei","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ejso.2024.108391_bib1","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1097\/AOG.0000000000005297","article-title":"ACOG clinical consensus No. 5","volume":"142","year":"2023","journal-title":"Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.ejso.2024.108391_bib2","doi-asserted-by":"crossref","first-page":"e124","DOI":"10.1097\/AOG.0000000000002631","article-title":"ACOG committee opinion no. 734: the role of transvaginal ultrasonography in evaluating the endometrium of women with postmenopausal bleeding","volume":"131","year":"2018","journal-title":"Obstet Gynecol"},{"issue":"30","key":"10.1016\/j.ejso.2024.108391_bib3","first-page":"125","article-title":"Management of endometrial hyperplasia","volume":"67","author":"No","year":"2016","journal-title":"RCOG BSGE Joint Guideline"},{"issue":"12","key":"10.1016\/j.ejso.2024.108391_bib4","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/j.jogc.2019.03.025","article-title":"Guideline no. 390-classification and management of endometrial hyperplasia","volume":"41","author":"Auclair","year":"2019","journal-title":"J\u00a0Obstet Gynaecol Can"},{"issue":"10","key":"10.1016\/j.ejso.2024.108391_bib5","first-page":"957","article-title":"Consensus on diagnosis and management of endometrial hyperplasia in China","volume":"26","year":"2017","journal-title":"J\u00a0Reprod Med"},{"key":"10.1016\/j.ejso.2024.108391_bib6","unstructured":"Lang J H, Leng J H, Deng S, Chen R, Zhou Y F. Chinese expert panel consensus recommendations on the clinical application of levonorgestrel-releasing intrauterine system[J]. Chin J Obstet Gynecol, 54(12): 815-825."},{"key":"10.1016\/j.ejso.2024.108391_bib7","series-title":"WHO classification of Tumours Female Genital Tumours[M]","volume":"5th vol. 4","year":"2020"},{"issue":"1","key":"10.1016\/j.ejso.2024.108391_bib8","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ejogrb.2009.09.023","article-title":"Premenopausal bleeding: when should the endometrium be investigated?\u2014a retrospective non-comparative study of 3006 women","volume":"148","author":"Iram","year":"2010","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"1","key":"10.1016\/j.ejso.2024.108391_bib9","article-title":"Therapeutic options for management of endometrial hyperplasia","volume":"27","author":"Chandra","year":"2016","journal-title":"J.\u00a0Gynecol. Oncol."},{"key":"10.1016\/j.ejso.2024.108391_bib10","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1055\/s-0031-1287662","article-title":"The FIGO recommendations on terminologies and definitions for normal and abnormal uterine bleeding[C]","author":"Fraser","year":"2011","journal-title":"Semin Reprod Med"},{"issue":"1","key":"10.1016\/j.ejso.2024.108391_bib11","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S1470-2045(10)70268-0","article-title":"Sensitivity of transvaginal ultrasound screening for endometrial cancer in postmenopausal women: a case-control study within the UKCTOCS cohort","volume":"12","author":"Jacobs","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejso.2024.108391_bib12","series-title":"Investigation of Post-menopausal bleeding[R]. Edinburgh, UK","author":"Sign","year":"2002"},{"issue":"1","key":"10.1016\/j.ejso.2024.108391_bib13","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/uog.22109","article-title":"Typical ultrasound features of various endometrial pathologies described using International Endometrial Tumor Analysis (IETA) terminology in women with abnormal uterine bleeding","volume":"57","author":"Van Den Bosch","year":"2021","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.ejso.2024.108391_bib14","doi-asserted-by":"crossref","first-page":"549.e1","DOI":"10.1016\/j.ajog.2020.03.032","article-title":"Risk assessment of endometrial cancer and endometrial intraepithelial neoplasia in women with abnormal bleeding and implications for clinical management algorithms","volume":"223","author":"Clarke","year":"2020","journal-title":"Am J Obstet Gynecol"},{"issue":"10","key":"10.1016\/j.ejso.2024.108391_bib15","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/S1701-2163(16)34690-4","article-title":"Asymptomatic endometrial thickening","volume":"32","author":"Wolfman","year":"2010","journal-title":"J\u00a0Obstet Gynaecol Can"},{"issue":"4","key":"10.1016\/j.ejso.2024.108391_bib16","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.ogc.2019.07.001","article-title":"Abnormal uterine bleeding","volume":"46","author":"Khafaga","year":"2019","journal-title":"Obstet Gynecol Clin N Am"},{"issue":"2","key":"10.1016\/j.ejso.2024.108391_bib17","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/ijgo.12787","article-title":"Three-dimensional 3D ultrasound combined with power Doppler for the differential diagnosis of endometrial lesions among infertile women","volume":"145","author":"Ni","year":"2019","journal-title":"Int J Gynaecol Obstet"},{"issue":"11","key":"10.1016\/j.ejso.2024.108391_bib18","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1002\/jum.15630","article-title":"The value of shear wave elastography in predicting the risk of endometrial cancer and atypical endometrial hyperplasia","volume":"40","author":"Ma","year":"2021","journal-title":"J\u00a0Ultrasound Med"},{"key":"10.1016\/j.ejso.2024.108391_bib19","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.clinimag.2016.10.016","article-title":"Role of diffusion weighted MRI in the differential diagnosis of endometrial cancer, polyp, hyperplasia, and physiological thickening","volume":"41","author":"Bakir","year":"2017","journal-title":"Clin Imag"},{"issue":"8","key":"10.1016\/j.ejso.2024.108391_bib20","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1080\/02841850903099981","article-title":"Diffusion-weighted magnetic resonance imaging of endometrial cancer: differentiation from benign endometrial lesions and preoperative assessment of myometrial invasion","volume":"50","author":"Takeuchi","year":"2009","journal-title":"Acta Radiol"},{"issue":"2","key":"10.1016\/j.ejso.2024.108391_bib21","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ygyno.2008.08.001","article-title":"The utility and cost effectiveness of preoperative computed tomography for patients with uterine malignancies","volume":"111","author":"Bansal","year":"2008","journal-title":"Gynecol Oncol"},{"issue":"12","key":"10.1016\/j.ejso.2024.108391_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/healthcare10122464","article-title":"Radiomics and molecular classification in endometrial cancer (the ROME study): a step forward to a simplified precision medicine","volume":"10","author":"Bogani","year":"2022","journal-title":"Healthcare"},{"issue":"6","key":"10.1016\/j.ejso.2024.108391_bib23","article-title":"Recent advances in endometrial cancer management","volume":"12","author":"Di Donato","year":"2023","journal-title":"J\u00a0Clin Med"},{"issue":"9","key":"10.1016\/j.ejso.2024.108391_bib24","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1034\/j.1600-0412.2001.080009784.x","article-title":"Accuracy of outpatient endometrial biopsy in the diagnosis of endometrial hyperplasia","volume":"80","author":"Clark","year":"2001","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.ejso.2024.108391_bib25","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ejogrb.2015.12.008","article-title":"The accuracy of endometrial sampling in women with postmenopausal bleeding: a systematic review and meta-analysis","volume":"197","author":"Van Hanegem","year":"2016","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"2","key":"10.1016\/j.ejso.2024.108391_bib26","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/CM9.0000000000001109","article-title":"Microscale endometrial sampling biopsy in detecting endometrial cancer and atypical hyperplasia in a population of 1551 women: a comparative study with hysteroscopic endometrial biopsy","volume":"134","author":"Zhang","year":"2020","journal-title":"Chin Med J"},{"issue":"5","key":"10.1016\/j.ejso.2024.108391_bib27","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1007\/s00404-012-2438-8","article-title":"Which is the best technique for endometrial sampling? Aspiration (pipelle) versus dilatation and curettage (D&C)","volume":"286","author":"Demirkiran","year":"2012","journal-title":"Arch Gynecol Obstet"},{"issue":"1","key":"10.1016\/j.ejso.2024.108391_bib28","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s12875-018-0817-3","article-title":"Endometrial sampling in low-risk patients with abnormal uterine bleeding: a systematic review and meta-synthesis","volume":"19","author":"Narice","year":"2018","journal-title":"BMC Fam Pract"},{"issue":"5","key":"10.1016\/j.ejso.2024.108391_bib29","first-page":"307","volume":"55","author":"Yu","year":"2020","journal-title":"Zhonghua Fu Chan Ke Za Zhi"},{"issue":"12","key":"10.1016\/j.ejso.2024.108391_bib30","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1007\/s00261-016-0930-5","article-title":"Through thick and thin: a pictorial review of the endometrium","volume":"41","author":"Caserta","year":"2016","journal-title":"Abdom Radiol (NY)"},{"key":"10.1016\/j.ejso.2024.108391_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.anndiagpath.2021.151726","article-title":"The pathogenesis of abnormal uterine bleeding in myopathic uteri","volume":"52","author":"Turner","year":"2021","journal-title":"Ann Diagn Pathol"},{"issue":"13","key":"10.1016\/j.ejso.2024.108391_bib32","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1001\/jama.288.13.1610","article-title":"Accuracy of hysteroscopy in the diagnosis of endometrial cancer and hyperplasia: a systematic quantitative review","volume":"288","author":"Clark","year":"2002","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.ejso.2024.108391_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics9040142","article-title":"Concordance between the hysteroscopic diagnosis of endometrial hyperplasia and histopathological examination","volume":"9","author":"De Franciscis","year":"2019","journal-title":"Diagnostics"},{"key":"10.1016\/j.ejso.2024.108391_bib34","series-title":"State-of-the-art hysteroscopic approaches to pathologies of the genital tract[M]","author":"Nappi","year":"2014"},{"issue":"2","key":"10.1016\/j.ejso.2024.108391_bib35","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/1097-0142(19850715)56:2<403::AID-CNCR2820560233>3.0.CO;2-X","article-title":"The behavior of endometrial hyperplasia. A long-term study of \"untreated\" hyperplasia in 170 patients","volume":"56","author":"Kurman","year":"1985","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.ejso.2024.108391_bib36","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1447-0756.1997.tb00836.x","article-title":"The behavior of endometrial hyperplasia: a prospective study. Endometrial Hyperplasia Study Group","volume":"23","author":"Terakawa","year":"1997","journal-title":"J\u00a0Obstet Gynaecol Res"},{"issue":"6","key":"10.1016\/j.ejso.2024.108391_bib37","doi-asserted-by":"crossref","first-page":"547.e1","DOI":"10.1016\/j.ajog.2010.07.037","article-title":"Oral progestogens vs levonorgestrel-releasing intrauterine system for endometrial hyperplasia: a systematic review and metaanalysis","volume":"203","author":"Gallos","year":"2010","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.ejso.2024.108391_bib38","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/humrep\/det049","article-title":"Relapse of endometrial hyperplasia after conservative treatment: a cohort study with long-term follow-up","volume":"28","author":"Gallos","year":"2013","journal-title":"Hum Reprod"},{"issue":"9","key":"10.1016\/j.ejso.2024.108391_bib39","article-title":"Levonorgestrel-releasing intrauterine system for endometrial hyperplasia","author":"Mittermeier","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"10.1016\/j.ejso.2024.108391_bib40","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1007\/s00404-015-3749-3","article-title":"Cyclic versus continuous medroxyprogesterone acetate for treatment of endometrial hyperplasia without atypia: a 2-year observational study","volume":"292","author":"Emarh","year":"2015","journal-title":"Arch Gynecol Obstet"},{"issue":"4","key":"10.1016\/j.ejso.2024.108391_bib41","first-page":"469","article-title":"Gynecology. Levonorgestrel-releasing intrauterine system vs oral progestins for non-atypical endometrial hyperplasia: a systematic review and metaanalysis of randomized trials[J]","volume":"213","author":"Hashim","year":"2015"},{"issue":"4","key":"10.1016\/j.ejso.2024.108391_bib42","article-title":"Comparison of diagnostic accuracy between endometrial curettage and aspiration biopsy in patients treated with progestin for endometrial hyperplasia: a Korean Gynecologic Oncology Group study","volume":"31","author":"Kim","year":"2020"},{"issue":"2","key":"10.1016\/j.ejso.2024.108391_bib43","first-page":"152","article-title":"A\u00a0comparison between the effects of metformin and megestrol on simple endometrial hyperplasia","volume":"33","author":"Sharifzadeh","year":"2017"},{"issue":"3","key":"10.1016\/j.ejso.2024.108391_bib44","first-page":"329","article-title":"Levonorgestrel-releasing intrauterine device versus dydrogesterone for management of endometrial hyperplasia without atypia","volume":"22","author":"El Behery","year":"2015"},{"issue":"4","key":"10.1016\/j.ejso.2024.108391_bib45","first-page":"448","article-title":"Depo-Provera versus norethisterone acetate in management of endometrial hyperplasia without atypia","volume":"23","author":"Nooh","year":"2016"},{"issue":"2","key":"10.1016\/j.ejso.2024.108391_bib46","first-page":"128","article-title":"LNG-IUS treatment of non-atypical endometrial hyperplasia in perimenopausal women: a randomized controlled trial","volume":"24","author":"Hashim","year":"2013"},{"issue":"3","key":"10.1016\/j.ejso.2024.108391_bib47","article-title":"Combined estrogen-progestin pill is a safe and effective option for endometrial hyperplasia without atypia: a three-year single center experience","volume":"30","author":"Wang","year":"2019"},{"key":"10.1016\/j.ejso.2024.108391_bib48","first-page":"1211","article-title":"Comparing the administration of letrozole and megestrol acetate in the treatment of women with simple endometrial hyperplasia without atypia: a randomized clinical trial","volume":"34","author":"Moradan","year":"2017"},{"issue":"2","key":"10.1016\/j.ejso.2024.108391_bib49","first-page":"479","article-title":"Regression of endometrial hyperplasia after treatment with the gonadotrophin-releasing hormone analogue triptorelin: a prospective study","volume":"14","author":"Grimbizis","year":"1999"},{"issue":"3","key":"10.1016\/j.ejso.2024.108391_bib50","first-page":"88","article-title":"Endometrial hyperplasia","volume":"23","author":"Moore","year":"2013"},{"issue":"5","key":"10.1016\/j.ejso.2024.108391_bib51","first-page":"562","article-title":"Diagnosis and management of endometrial hyperplasia","volume":"19","author":"Armstrong","year":"2012"},{"issue":"1","key":"10.1016\/j.ejso.2024.108391_bib52","first-page":"69","article-title":"Gynecology, Biology R. Feasibility of endometrial assessment after thermal ablation","volume":"147","author":"Ahonkallio","year":"2009"},{"issue":"1","key":"10.1016\/j.ejso.2024.108391_bib53","first-page":"30","article-title":"Hysteroscopic appearance of endometrial cavity after microwave endometrial ablation[J]","volume":"17","author":"Luo","year":"2010"},{"issue":"3","key":"10.1016\/j.ejso.2024.108391_bib54","first-page":"393","article-title":"Endometrial cancer after endometrial ablation: systematic review of medical literature","volume":"18","author":"Alhilli","year":"2011"},{"issue":"11","key":"10.1016\/j.ejso.2024.108391_bib55","first-page":"2966","article-title":"LNG-IUS versus oral progestogen treatment for endometrial hyperplasia: a long-term comparative cohort study","volume":"28","author":"Gallos","year":"2013"},{"issue":"5","key":"10.1016\/j.ejso.2024.108391_bib56","first-page":"640","article-title":"Non-contraceptive benefits of hormonal and intrauterine reversible contraceptive methods","volume":"21","author":"Bahamondes","year":"2015"},{"issue":"5","key":"10.1016\/j.ejso.2024.108391_bib57","first-page":"1160","article-title":"Gynecology. Management of endometrial precancers","volume":"120","author":"Trimble","year":"2012"},{"issue":"9","key":"10.1016\/j.ejso.2024.108391_bib58","first-page":"CD012658","article-title":"Levonorgestrel-releasing intrauterine system for endometrial hyperplasia","volume":"9","author":"Mittermeier","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ejso.2024.108391_bib59","series-title":"Laparoscopy versus laparotomy for the management of early stage endometrial cancer","author":"Galaal","year":"2018"},{"issue":"6","key":"10.1016\/j.ejso.2024.108391_bib60","first-page":"480","article-title":"No. 344-Opportunistic salpingectomy and other methods of risk reduction for ovarian\/fallopian tube\/peritoneal cancer in the general population","volume":"39","author":"Salvador","year":"2017"},{"issue":"2","key":"10.1016\/j.ejso.2024.108391_bib61","first-page":"396","article-title":"Gynecology. Long-term mortality associated with oophorectomy compared with ovarian conservation in the nurses' Health study reply","volume":"122","author":"Parker","year":"2013"},{"issue":"5","key":"10.1016\/j.ejso.2024.108391_bib62","first-page":"e40","article-title":"Gynecology. The accuracy of frozen pathology at time of hysterectomy in patients with complex atypical hyperplasia on preoperative biopsy","volume":"196","author":"Indermaur","year":"2007"},{"key":"10.1016\/j.ejso.2024.108391_bib63","series-title":"Lymphadenectomy for the management of endometrial cancer","author":"Frost","year":"2017"},{"issue":"6","key":"10.1016\/j.ejso.2024.108391_bib64","first-page":"739","article-title":"Accuracy of preoperative tumor grade and intraoperative gross examination of myometrial invasion in patients with endometrial cancer","volume":"86","author":"Traen","year":"2007"},{"issue":"1","key":"10.1016\/j.ejso.2024.108391_bib65","first-page":"3","article-title":"An update on post-treatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncology (SGO) recommendations","volume":"146","author":"Salani","year":"2017"},{"issue":"8","key":"10.1016\/j.ejso.2024.108391_bib66","first-page":"888","article-title":"NCCN Guidelines\u00ae insights: uterine neoplasms, version 3.2021: featured updates to the NCCN guidelines","volume":"19","author":"Abu-Rustum","year":"2021"},{"issue":"4","key":"10.1016\/j.ejso.2024.108391_bib67","first-page":"812","article-title":"Concurrent endometrial carcinoma in women with a biopsy diagnosis of atypical endometrial hyperplasia: a Gynecologic Oncology Group study","volume":"106","author":"Trimble","year":"2006"},{"issue":"6","key":"10.1016\/j.ejso.2024.108391_bib68","first-page":"866","article-title":"Biopsy histomorphometry predicts uterine myoinvasion by endometrial carcinoma: a Gynecologic Oncology Group study","volume":"39","author":"Mutter","year":"2008"},{"issue":"10","key":"10.1016\/j.ejso.2024.108391_bib69","article-title":"Prevalence of co-existing endometrial carcinoma in patients with preoperative diagnosis of endometrial hyperplasia","volume":"9","author":"Kadirogullari","year":"2015"},{"issue":"5","key":"10.1016\/j.ejso.2024.108391_bib70","first-page":"474. e1","article-title":"Gynecology. National patterns of care and fertility outcomes for reproductive-aged women with endometrial cancer or atypical hyperplasia","volume":"221","author":"Harrison","year":"2019"},{"issue":"2","key":"10.1016\/j.ejso.2024.108391_bib71","first-page":"80","article-title":"Consensus on fertility preservation treatment for early stage endometrial cancer and atypical hyperplasia","volume":"54","author":"Xiaojun","year":"2019","journal-title":"Chin J Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.ejso.2024.108391_bib72","doi-asserted-by":"crossref","first-page":"191.e1","DOI":"10.1016\/j.ajog.2020.08.032","article-title":"Prospective phase II trial of levonorgestrel intrauterine device: nonsurgical approach for complex atypical hyperplasia and early-stage endometrial cancer","volume":"224","author":"Westin","year":"2021","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.ejso.2024.108391_bib73","doi-asserted-by":"crossref","first-page":"103.e1","DOI":"10.1016\/j.ajog.2019.12.273","article-title":"Progestin therapy for obese women with complex atypical hyperplasia: levonorgestrel-releasing intrauterine device vs systemic therapy","volume":"223","author":"Mandelbaum","year":"2020","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.ejso.2024.108391_bib74","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/AOG.0000000000002390","article-title":"Treatment of low-risk endometrial cancer and complex atypical hyperplasia with the levonorgestrel-releasing intrauterine device","volume":"131","author":"Pal","year":"2018","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.ejso.2024.108391_bib75","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/ijgo.12887","article-title":"Treatment of symptomatic adenomyosis with the levonorgestrel-releasing intrauterine system","volume":"146","author":"Li","year":"2019","journal-title":"Int J Gynaecol Obstet"},{"issue":"6","key":"10.1016\/j.ejso.2024.108391_bib76","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1097\/IGC.0000000000001008","article-title":"Gonadotropin-releasing hormone agonist combined with a levonorgestrel-releasing intrauterine system or letrozole for fertility-preserving treatment of endometrial carcinoma and complex atypical hyperplasia in young women","volume":"27","author":"Zhou","year":"2017","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"10.1016\/j.ejso.2024.108391_bib77","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1006\/gyno.1997.4639","article-title":"Treatment of endometrial hyperplasias with gonadotropin-releasing hormone agonists: pathological, clinical, morphometric, and DNA-cytometric data","volume":"65","author":"Agorastos","year":"1997","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2024.108391_bib78","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ygyno.2014.02.020","article-title":"Fertility sparing treatment of complex atypical hyperplasia and low grade endometrial cancer using oral progestin","volume":"133","author":"Simpson","year":"2014","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2024.108391_bib79","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.ygyno.2012.01.003","article-title":"Oncologic and reproductive outcomes with progestin therapy in women with endometrial hyperplasia and grade 1 adenocarcinoma: a systematic review","volume":"125","author":"Gunderson","year":"2012","journal-title":"Gynecol Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2024.108391_bib80","doi-asserted-by":"crossref","first-page":"266.e1","DOI":"10.1016\/j.ajog.2012.08.011","article-title":"Regression, relapse, and live birth rates with fertility-sparing therapy for endometrial cancer and atypical complex endometrial hyperplasia: a systematic review and metaanalysis","volume":"207","author":"Gallos","year":"2012","journal-title":"Am J Obstet Gynecol"},{"issue":"9","key":"10.1016\/j.ejso.2024.108391_bib81","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1111\/1471-0528.13763","article-title":"Relapse risk of endometrial hyperplasia after treatment with the levonorgestrel-impregnated intrauterine system or oral progestogens","volume":"123","author":"\u00d8rbo","year":"2016","journal-title":"Bjog"},{"issue":"1","key":"10.1016\/j.ejso.2024.108391_bib82","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ijgo.2015.06.046","article-title":"Oncologic and reproductive outcomes after fertility-sparing management with oral progestin for women with complex endometrial hyperplasia and endometrial cancer","volume":"132","author":"Chen","year":"2016","journal-title":"Int J Gynaecol Obstet"},{"issue":"1","key":"10.1016\/j.ejso.2024.108391_bib83","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ygyno.2012.12.037","article-title":"Progestin re-treatment in patients with recurrent endometrial adenocarcinoma after successful fertility-sparing management using progestin","volume":"129","author":"Park","year":"2013","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2024.108391_bib84","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s12958-021-00808-y","article-title":"Analysis of pregnancy-associated factors after fertility-sparing therapy in young women with early stage endometrial cancer or atypical endometrial hyperplasia","volume":"19","author":"Fan","year":"2021","journal-title":"Reprod Biol Endocrinol"},{"issue":"1","key":"10.1016\/j.ejso.2024.108391_bib85","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ygyno.2021.01.001","article-title":"Live births and maintenance with levonorgestrel IUD improve disease-free survival after fertility-sparing treatment of atypical hyperplasia and early endometrial cancer","volume":"161","author":"Novikova","year":"2021","journal-title":"Gynecol Oncol"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798324004438?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798324004438?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,29]],"date-time":"2024-06-29T19:55:24Z","timestamp":1719690924000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798324004438"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":85,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S0748798324004438"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2024.108391","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chinese guidelines on the management of endometrial hyperplasia","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2024.108391","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108391"}}